Antiplatelet therapy following conservatively managed spontaneous coronary artery dissection

Madeline K Mahowald1, Luis Ortega-Paz2, Claudio Laudani2,3

  • 1Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA. madeline.mahowald@jax.ufl.edu.

Insights

Spontaneous coronary artery dissection (SCAD) requires optimal medical therapy, but current antiplatelet strategies are unclear. This review analyzes data and offers recommendations for antiplatelet use in SCAD patients.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute coronary syndrome (ACS).
  • Optimal medical therapy for SCAD remains undefined.
  • Current treatment often follows guidelines for plaque-rupture ACS, using dual antiplatelet therapy (DAPT).

Purpose of the Study:

  • To review existing data on antiplatelet therapy in SCAD.
  • To analyze the impact of antiplatelet therapy on major adverse cardiac events (MACE) post-SCAD.
  • To provide clinical recommendations for antiplatelet management after conservative SCAD treatment.

Main Methods:

  • Comprehensive literature review of antiplatelet therapy in SCAD.
  • Inclusion of a meta-analysis of observational studies.
  • Synthesis of evidence to formulate clinical practice recommendations.

Main Results:

  • Observational studies show conflicting results regarding DAPT efficacy in SCAD.
  • Evidence supporting standard DAPT in SCAD is limited and derived from different ACS etiologies.
  • Further research is needed to clarify optimal antiplatelet strategies.

Conclusions:

  • Current recommendations for antiplatelet therapy in SCAD are based on limited evidence.
  • Conflicting data necessitates a cautious approach to DAPT in SCAD.
  • Clinical practice guidelines should be updated based on specific SCAD data and ongoing research.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
40
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
34
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
656
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
36
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
34
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
47